177 related articles for article (PubMed ID: 3859122)
1. Ultrastructural studies of cells in body cavity effusions.
Bewtra C; Greer KP
Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
[TBL] [Abstract][Full Text] [Related]
2. Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumour).
Mukherjee TM; Swift JG; Henderson DW
J Submicrosc Cytol Pathol; 1988 Jan; 20(1):195-208. PubMed ID: 3370618
[TBL] [Abstract][Full Text] [Related]
3. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
Kobzik L; Antman KH; Warhol MJ
Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
Kahn HJ; Hanna W; Yeger H; Baumal R
Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
[TBL] [Abstract][Full Text] [Related]
6. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
Yang GC
Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
[TBL] [Abstract][Full Text] [Related]
7. [Ultrastructural diagnostic problems of pleural tumors. A study of 125 cases (author's transl)].
Stoebner P; Bernaudin JF; Adnet JJ; Basset F
Rev Fr Mal Respir; 1979; 7(3):265-76. PubMed ID: 573917
[TBL] [Abstract][Full Text] [Related]
8. Scope of scanning electron microscopy, transmission electron microscopy and freeze fracture technique in diagnostic cytology of effusions.
Mukherjee TM; Smith K; Swift JG
Scan Electron Microsc; 1983; (Pt 3):1317-27. PubMed ID: 6648341
[TBL] [Abstract][Full Text] [Related]
9. Transmission and scanning electron microscopic studies of cells in effusions.
Domagala W; Woyke S
Acta Cytol; 1975; 19(3):214-24. PubMed ID: 1056674
[TBL] [Abstract][Full Text] [Related]
10. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
12. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
Marsan C; Gaulier A; Sabatier P; Garcia R
Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
Sakuma N; Kamei T; Ishihara T
Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
[TBL] [Abstract][Full Text] [Related]
14. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
15. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
Warhol MJ; Hickey WF; Corson JM
Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a possible new protein marker for differential diagnosis between metastatic carcinoma and mesothelioma cells in serous effusions: preliminary findings.
Donna A; Betta PG; Marchesini A
Cancer Detect Prev; 1985; 8(1-2):255-60. PubMed ID: 4064046
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
18. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
19. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
20. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
Su XY; Li GD; Liu HB; Jiang LL
Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
